Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population
doi: 10.3389/fneur.2022.1012668
Periodically, the growth of the market has been constrained by supply due to supply shortages, and the manufacturing capacity has been significantly invested in by manufacturers Novo Nordisk and Eli Lilly to meet the increasing demand of over USD 15 billion combined in 2023-2024
Connection between weight loss and better sleep Obesity represents the primary modifiable risk factor for obstructive sleep apnea (OSA) 34
Estradiol nasal therapy has been explored as a method to increase mucosal edema and support Eustachian tube closure in select patients
We recommend our Alliwise Glutathione Supplement, which uses liposomal technology designed for enhanced absorption, aiming to help you gain the benefits of a quality glutathione supplement